The Centre for Commercialization of Regenerative Medicine’s (CCRM) industry consortium is growing with the addition of 13 new companies to its associate membership category. CCRM’s industry consortium is now a group of almost 40 companies formed to address bottlenecks in regenerative medicine product pipelines by enabling industry to engage with CCRM’s broad network of researchers and institutions.
“CCRM’s industry consortium is critical to build a global regenerative medicine nexus in Canada,” says Michael May, president and CEO of CCRM. “By establishing collaborative projects with our industry consortium members, we are not only accelerating the development of products to market, but we are also creating jobs.”
The companies joining CCRM’s industry consortium as associate members include Blood Centers of America, Compass Biomedical, ATCC, BioLife Solutions, Cell Scale, Life Technologies, Medinet, Miltenyi, Nikon, Primorigen Biosciences, PCT, Sistemic and Steminent.
CCRM’s industry consortium includes representatives from the key sectors in regenerative medicine – therapeutics, devices, reagents, and cells as tools. To balance the demand for new membership and CCRM’s responsibility to maintain an effective and efficient consortium, it has added an associate membership category.
For a full list of CCRM’s industry consortium and associate members, please visit http://www.ccrm.ca/industry-consortium.